Jaylon Johnson returns to practice
Digest more
Mike Johnson swears in Adelita Grijalva
Digest more
Johnson addresses House vote to end government shutdown
Digest more
The Chicago Bears will be tested by the Minnesota Vikings defense in ways that recent opponents haven't. It will be a real measurement of Caleb Williams' progress.
Thirty-four years ago, Magic Johnson shocked the world by announcing that he had contracted the human immunodeficiency virus (HIV), which causes AIDS. He admitted that it was one of the toughest episodes in his life, but one he was able to navigate with the love and support of his wife, Cookie.
Ald. Pat Dowell told reporters she advised Mayor Brandon Johnson’s administration not to proceed with a budget vote in her Finance Committee.
Tampa Bay Buccaneers rookie wide receiver Tez Johnson has burst onto the scene in the NFL, catching two touchdowns in Tampa Bay's 28-23 loss to the New England
Calvin Johnson’s dominant career left so many good memories for the Detroit Lions and NFL fans. The wide receiver was one of the best players of his generation, putting up a show week in and week out with Matthew Stafford at Ford Field.
The Eagles are set to have their entire offensive line available for Sunday's game against the Lions.
Zacks Investment Research on MSN
Wall Street Analysts See Johnson & Johnson (JNJ) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price,
Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE: JNJ) we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 25% with bearish.
Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS markets. Learn why JNJ stock is a buy.